Yilon Lima Cheng1, Enrique F Elli2. 1. Division of General Surgery, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. 2. Division of General Surgery, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. elli.enrique@mayo.edu.
Abstract
PURPOSE: Revisional bariatric surgery (RBS) is becoming more common, with an estimated increase of more than 300% from 2017 to 2018. For these complex procedures, the role of robotics is still debated. The purpose of our study is to report the safety and effectiveness of robotic-assisted RBSs. MATERIALS AND METHODS: A retrospective review of electronic medical records was conducted for robotic-assisted RBSs performed at the Mayo Clinic in Florida, between January 1, 2016, and January 1, 2020. Peri- and postoperative data were analyzed, reviewing patient characteristics, indications for surgery, and outcomes. RESULTS: From 160 RBSs performed during the study period, 67 were robotic-assisted and met inclusion criteria. Primary procedures included sleeve gastrectomy (26 [38.8%]), adjustable gastric band (24 [35.8%]), Roux-en-Y gastric bypass (14 [20.9%]), vertical-banded gastroplasty (2 [3.0%]), and duodenal switch (1 [1.5%]). RBSs performed were Roux-en-Y gastric bypass (49 [73.1%]), redo gastrojejunostomy (14 [20.9%]), and duodenal switch (4 [6.0%]). Rate of conversion to open procedure and rate of readmission 1 month after surgery were 6.0% and 7.5%, respectively. Rate of 30-day Clavien-Dindo grade III or higher adverse events was 4.5%. No anastomotic leaks were documented. Fifty-two patients presented with preoperative symptoms, and 69.2% reported improvement after RBS. Mean (SD) excess weight loss was 57.62% (23.80) 12 months after RBS. CONCLUSION: Robotic-assisted RBSs are safe with low major adverse event rates. Symptom resolution and weight loss outcomes are acceptable.
PURPOSE: Revisional bariatric surgery (RBS) is becoming more common, with an estimated increase of more than 300% from 2017 to 2018. For these complex procedures, the role of robotics is still debated. The purpose of our study is to report the safety and effectiveness of robotic-assisted RBSs. MATERIALS AND METHODS: A retrospective review of electronic medical records was conducted for robotic-assisted RBSs performed at the Mayo Clinic in Florida, between January 1, 2016, and January 1, 2020. Peri- and postoperative data were analyzed, reviewing patient characteristics, indications for surgery, and outcomes. RESULTS: From 160 RBSs performed during the study period, 67 were robotic-assisted and met inclusion criteria. Primary procedures included sleeve gastrectomy (26 [38.8%]), adjustable gastric band (24 [35.8%]), Roux-en-Y gastric bypass (14 [20.9%]), vertical-banded gastroplasty (2 [3.0%]), and duodenal switch (1 [1.5%]). RBSs performed were Roux-en-Y gastric bypass (49 [73.1%]), redo gastrojejunostomy (14 [20.9%]), and duodenal switch (4 [6.0%]). Rate of conversion to open procedure and rate of readmission 1 month after surgery were 6.0% and 7.5%, respectively. Rate of 30-day Clavien-Dindo grade III or higher adverse events was 4.5%. No anastomotic leaks were documented. Fifty-two patients presented with preoperative symptoms, and 69.2% reported improvement after RBS. Mean (SD) excess weight loss was 57.62% (23.80) 12 months after RBS. CONCLUSION: Robotic-assisted RBSs are safe with low major adverse event rates. Symptom resolution and weight loss outcomes are acceptable.
Authors: Antoine Vallois; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Hugo Meunier; Thomas Gautier; Nicolas Contival; Andrea Mulliri; Jean Lubrano; Jean-Jacques Parienti; A Alves Journal: Obes Surg Date: 2019-03 Impact factor: 4.129
Authors: Essa M Aleassa; Monique Hassan; Kellen Hayes; Stacy A Brethauer; Philip R Schauer; Ali Aminian Journal: Surg Endosc Date: 2018-10-19 Impact factor: 4.584
Authors: Tomasz Rogula; Marijan Koprivanac; Michał Robert Janik; Jacob A Petrosky; Amy S Nowacki; Agnieszka Dombrowska; Matthew Kroh; Stacy Brethauer; Ali Aminian; Philip Schauer Journal: Obes Surg Date: 2018-09 Impact factor: 4.129
Authors: Raul Sebastian; Omar M Ghanem; Jorge Cornejo; Thomas Ruttger; Matthew Mayuiers; Gina Adrales; Christina Li Journal: Surg Endosc Date: 2022-01-12 Impact factor: 3.453
Authors: Carolina Vanetta; Nicolás H Dreifuss; Francisco Schlottmann; Alberto Mangano; Antonio Cubisino; Valentina Valle; Carolina Baz; Francesco M Bianco; Chandra Hassan; Antonio Gangemi; Mario A Masrur Journal: J Clin Med Date: 2022-03-25 Impact factor: 4.241